GRACEcast ALL Subjects audio and video
ASCO Lung Cancer Highlights, Part 11: Nintedanib with Second Line Chemotherapy for Advanced NSCLC (audio)
- Autor: Podcast
- Narrador: Podcast
- Editor: Podcast
- Duración: 0:05:21
- Mas informaciones
Informações:
Sinopsis
Dr. Edward Garon, David Geffen School of Medicine at UCLA, discusses results in a trial that demonstrated a significant survival benefit with nintedanib combined with second line docetaxel in advanced lung adenocarcinoma.
